Name: UMIN ID:
Unique ID issued by UMIN | UMIN000018322 |
---|---|
Receipt number | R000021197 |
Scientific Title | Phase II study of carboplatin, weekly paclitaxel and bevacizumab for advanced non-squamous cell, non-small-cell lung cancer with idiopathic interstitial pneumonia |
Date of disclosure of the study information | 2015/07/15 |
Last modified on | 2018/01/24 00:56:40 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/07/15 17:48:44 | ||
2 | Update | 2016/03/13 15:04:56 | Email1 |
|
3 | Update | 2018/01/24 00:20:11 | Key inclusion criteria |
|
4 | Update | 2018/01/24 00:56:40 | Organization Organization Division name Division name Address Address TEL Name of primary person or sponsor Organization |